| 生物活性 | |||
|---|---|---|---|
| 描述 | SR11237, also known as BMS-649, is a potent, selective retinoid X receptor (RXR) agonist with no RAR activity. SR11237 results in the formation of RXR/RXR homodimers and transactivation of reporter genes containing RXR response elements[1][2][3]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
2.63mL 0.53mL 0.26mL |
13.14mL 2.63mL 1.31mL |
26.28mL 5.26mL 2.63mL |
| 参考文献 |
|---|
|
[3]H.L. Dupuis. The RXR agonist SR-11237 affects skeletal development. ABSTRACT ONLY |